GleamWall
中文EN

PRCT PROCEPT BioRobotics Corp

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1588978 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY17.5%
TTM net income YoY-35.8%
TTM EPS YoY-32.0%
Revenue 3-yr CAGR44.7%
Net income 3-yr CAGR—

Margins

Gross margin64.7%
Operating margin-33.6%
Net margin-32.6%
FCF margin-24.1%
EBITDA margin-31.3%

Returns

ROE-32.4%
ROA-23.3%
ROIC (approx.)-62.4%
Asset turnover0.72x

Leverage & solvency

Liabilities / assets30.6%
Debt / equity0.16x
Current ratio5.89x
Interest coverage-34.73x

Cash quality & payout

Operating cash flow / net income0.67x
Accruals ratio-7.7%
Payout ratio—
Capex / revenue2.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$308.05M$224.50M
Cost of revenue$111.83M$87.40M
Gross profit$196.23M$137.10M
R&D expense$71.28M$62.30M
SG&A expense$228.81M$171.41M
Operating income-$103.86M-$96.61M
Interest expense$3.59M$4.18M
Pretax income-$95.38M-$91.05M
Income tax$190,000$368,000
Net income-$95.57M-$91.41M
EBITDA-$97.47M-$91.38M
EPS (basic)-1.72-1.75
EPS (diluted)-1.72-1.75
Weighted avg. shares (diluted)55.54M52.12M
Banking
Provision for credit losses—$840,000
Balance sheet
Cash & equivalents$286.50M$336.76M
Receivables$83.53M$83.50M
Inventory$70.69M$56.17M
Current assets$450.38M$481.84M
PP&E, net$30.40M$26.71M
Total assets$508.08M$534.02M
Current liabilities$65.80M$53.13M
Long-term debt$51.62M$51.47M
Total debt$51.62M$51.47M
Total liabilities$142.21M$131.80M
Shareholders' equity$365.87M$402.22M
Net debt-$234.89M-$285.29M
Shares outstanding56.32M54.72M
Cash flow statement
Operating cash flow-$48.98M-$99.21M
Capital expenditure$9.36M$4.41M
Free cash flow-$58.34M-$103.62M
Investing cash flow-$9.36M-$4.41M
Financing cash flow$11.19M$180.12M
Depreciation & amortization$6.39M$5.23M
Stock-based compensation$47.60M$31.84M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.